Successful therapy of systemic xanthogranuloma in a child

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 6, 2007, Pages 425-427

  Unuvar, Emin ^a,b   Devecioglu, Omer ^a   Akcay, Arzu ^a   Gulluoglu, Mine ^a   Uysal, Veli ^a   Oguz, Fatma ^a   Sidal, Müjgan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Tunusbagi Caddesi Melek ISIK Apt:6 D:3   (Turkey)

Author keywords

Child; Histiocytosis; Xanthogranuloma

Indexed keywords

CD68 ANTIGEN; METHYLPREDNISOLONE; PROTEIN S 100; T6 ANTIGEN;

ARTICLE; CASE REPORT; CHILD; DRUG MEGADOSE; FOLLOW UP; HUMAN; JUVENILE XANTHOGRANULOMA; KIDNEY BIOPSY; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MACROPHAGE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHILD; HUMANS; MALE; METHYLPREDNISOLONE; TREATMENT OUTCOME; XANTHOGRANULOMA, JUVENILE;

EID: 34249997550     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318064515e     Document Type: Article

References (15)

1. Freyer DR, Kennedy R, Bostrom BC. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;129:227-237.
2. Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the Kiel pediatric tumor registry. Am J Surg Pathol. 2005;29:21-28.
3. Chantranuwat C. Systemic form of juvenile xanthogranuloma: report of case with liver and bone marrow involvement. Pediatric Dev Pathol. 2004;7:646-648.
4. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27:579-593.
5. Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45:256-264.
6. Favara BE, Jaffe R. Pathology of Langerhans histiocytosis. Hematol Oncol Clin North Am. 1986;1:75-82.
7. Kenn W, Eck M, Allolio B, et al. Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis. Hum Pathol. 2000;31:734-739.
8. Eyigar S, Kirazl? Y, Memis A, et al. Erdheim-Chester disease: the effect of biphosphonate treatment: a case report. Arch Phys Med Rehabil. 2005;86:1053-1057.
9. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine. 1996;75:157-169.
10. Gilbert TJ, Parker BR. Juvenile xanthogranuloma of the kidney. Pediatr Radiol. 1988;18:169-171.
11. Guthrie JA, Arthur RJ. Case report: juvenile xanthogranuloma with pulmonary, subcutaneous and hepatic involvement. Clin Radiol. 1994;49:498-500.
12. Dolken R, Weigel S, Schroder H, et al. Treatment of severe disseminated juvenile xanthogranuloma with multiple lesions in the central nervous system. J Pediatr Hematol Oncol. 2006;28:95-97.
13. Broker LE, van den Berg H, van Groningen K, et al. Juvenile xanthogranuloma: a rare form of histiocytosis with an excellent prognosis. Ned Tijdschr Geneeskd. 2001;145:635-639.
14. Jendro MC, Zeidler H, Rosenthal M, et al. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol. 2003;23:52-56.
15. Chang MW, Frieden IJ, Good W. The risk of intraocular juvenile xanthogranuloma: survey of current practices and assessment of risk. J Am Acad Dermatol. 1996;34:445-449.